Science policy implications to DNA recombinant molecule researchU.S. Government Printing Office, 1977 - 1293 pages |
From inside the book
Results 1-3 of 76
Page 366
... Thank you . Do any of you have any further comments ? [ No response . ] I want to think you . The response has been ... Thank you very much . Dr. PIECZENIK . Thank you , Mr. Chairman . Dr. RYAN . Thank you . Dr. CHARACHE . Thank you , Mr ...
... Thank you . Do any of you have any further comments ? [ No response . ] I want to think you . The response has been ... Thank you very much . Dr. PIECZENIK . Thank you , Mr. Chairman . Dr. RYAN . Thank you . Dr. CHARACHE . Thank you , Mr ...
Page 502
... thank you for your statement . I would like to mention very briefly one element of your statement , and ask if any other committee members have any clarifying questions before we proceed to the other panel members . I was struck by your ...
... thank you for your statement . I would like to mention very briefly one element of your statement , and ask if any other committee members have any clarifying questions before we proceed to the other panel members . I was struck by your ...
Page 579
... thank the witnesses . Thank you . Mr. THORNTON . Thank you very much for your good questioning . I would like to recognize Mr. Pursell , who is here in preparation for our markup session , to make such statements or ask such ques- tions ...
... thank the witnesses . Thank you . Mr. THORNTON . Thank you very much for your good questioning . I would like to recognize Mr. Pursell , who is here in preparation for our markup session , to make such statements or ask such ques- tions ...
Contents
Technology Cambridge Mass | 133 |
Dr Ethan Signer professor of biology Massachusetts Institute | 139 |
Dr David Baltimore American Cancer Society research professor | 158 |
1 other sections not shown
Common terms and phrases
activities agencies amendment American analysis antibiotic resistance antibiotics anticodon Association bacteria bacterium basic benefits biohazards biological containment cancer cells Chairman THORNTON chemical citizen coli Committee concern conduct Congress decision discussion disease DNA recombinant drug environment environmental example experiments facilities Federal Fort Detrick Fredrickson freedom genes genetic engineering George Wald going groups hazards hearings human industry insulin interest involved issue knowledge laboratory legislation licensing Lilly ment microorganisms molecular molecular biology molecule research National nature NIH guidelines nuclear organisms patent pathogenic PIECZENIK plasmid political possible potential present problem procedures production protection protein question recombinant DNA molecules recombinant DNA research recombinant DNA technology regulation require responsibility risk risk-benefit risk-benefit analysis safety scientific community scientists Secretary Sinsheimer social society specific statement strains Subcommittee suggested testimony Thank things tion tRNA University viruses